Vaccination with Leishmania mexicana LPG induces PD-1 in CD8+ and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy
M.B.Mart\'inez Salazar, J.Delgado Dom\'inguez, J.Silva Estrada,, C.Gonz\'alez Bonilla, I.Becker

TL;DR
This study investigates how Leishmania mexicana LPG vaccination influences immune inhibitory molecules, revealing dose-dependent expression of PD-1 and PD-L2 that may suppress immune responses and affect vaccine efficacy.
Contribution
It demonstrates that LPG vaccination and infection levels modulate inhibitory receptor expression, providing insights into vaccine design and immune regulation in leishmaniasis.
Findings
LPG vaccination increases PD-1 expression in CD8+ T cells.
Higher parasite loads elevate PD-1 and reduce PD-L2 expression.
In vitro LPG re-stimulation enhances PD-L2 expression in macrophages.
Abstract
Leishmania lipophosphoglycan is a molecule that has been used as a vaccine candidate, with contradictory results. Since unsuccessful protection could be related to suppressed T cell responses, we analyzed the expression of inhibitory receptor PD-1 in CD8+ and CD4+ lymphocytes and it is ligand PD-L2 in macrophages of BALB/c mice immunized with various doses of Leishmania mexicana LPG and re-stimulated in vitro with different concentrations of LPG. Vaccination with LPG enhanced the expression of PD-1 in CD8+ cells. Activation molecules CD137 were reduced in CD8+ cells from vaccinated mice. In vitro re-stimulation enhanced PD-L2 expression in macrophages of healthy mice in a dose-dependent fashion. The expression of PD-1, PD-L2, and CD137 is modulated according to the amount of LPG used during immunization and in vitro re-stimulation. We analyzed the expression of these molecules in mice…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
